Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study
- PMID: 34853103
- PMCID: PMC8638452
- DOI: 10.1136/bmjopen-2021-049831
Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study
Abstract
Objectives: Risk of infections in patients with solid cancers and bone metastases (BM) and the subsequent impact on prognosis is unclear. We examined the risk of infections among patients with cancer diagnosed with BM and the subsequent impact of infections on mortality.
Design: Population-based cohort study.
Setting: Danish medical databases holding information on all hospital contacts in Denmark.
Participants: Adult patients with solid cancers and BM between 1 January 1994 and 30 November 2013.
Outcome measures: In the risk analyses, the outcome was time to hospitalisation for common severe infections, pneumonia, sepsis and urinary tract infections. In the mortality analysis, we used Cox regression to compute HRs of death, modelling infection as time-varying exposure, stratifying for primary cancer type and adjusting for age, sex and comorbidities.
Results: Among 23 336 patients with cancer and BM, cumulative incidences of common severe infections were 4.6%, 14.0% and 20.0% during 1 month, 1 year and 10 years follow-up. The highest incidence was observed for pneumonia, followed by urinary tract infections and sepsis. Infection was a strong predictor of 1 month mortality (adjusted HR: 2.1 (95% CI 1.8 to 2.3)) and HRs increased after 1 and 10 years: 2.4 (95% CI 2.3 to 2.6) and 2.4 (95% CI 2.4 to 2.6). Sepsis and pneumonia were the strongest predictors of death. Results were consistent across cancer types.
Conclusion: Patients with cancer and BM were at high risk of infections, which was associated with a more than twofold increased risk of death for up to 10 years of follow-up. The findings underscore the importance of preventing infections in patients with cancer and BM.
Keywords: bone metastasis; cancer; cohort study; complications; infection; mortality.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: The analysis, presentation, and interpretation of the results are solely the responsibility of the authors. AS, RH, and AM are employees of and own shares in Amgen Inc. TH, TR, HTS, and AP are salaried employees of Aarhus University/Aarhus University Hospital and have no personal conflicts of interest to declare. NO is employed at Copenhagen University Hospital and has no conflict of interest to declare.
Figures
Similar articles
-
Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.BMJ Open. 2017 Sep 11;7(9):e016022. doi: 10.1136/bmjopen-2017-016022. BMJ Open. 2017. PMID: 28893744 Free PMC article.
-
Cardiovascular events in cancer patients with bone metastases-A Danish population-based cohort study of 23,113 patients.Cancer Med. 2021 Jul;10(14):4885-4895. doi: 10.1002/cam4.4027. Epub 2021 Jun 2. Cancer Med. 2021. PMID: 34076356 Free PMC article.
-
Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.BMJ Open. 2015 Apr 29;5(4):e007702. doi: 10.1136/bmjopen-2015-007702. BMJ Open. 2015. PMID: 25926150 Free PMC article.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Surgical treatment for urinary incontinence in women - Danish nationwide cohort studies .Dan Med J. 2018 Feb;65(2):B5447. Dan Med J. 2018. PMID: 29393041 Review.
Cited by
-
Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.BMJ Open. 2023 May 8;13(5):e069214. doi: 10.1136/bmjopen-2022-069214. BMJ Open. 2023. PMID: 37156580 Free PMC article.
-
Antibiotic Therapy in Integrated Oncology and Palliative Cancer Care: An Observational Study.Cancers (Basel). 2022 Mar 22;14(7):1602. doi: 10.3390/cancers14071602. Cancers (Basel). 2022. PMID: 35406374 Free PMC article.
-
Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections.Front Cell Infect Microbiol. 2022 Sep 20;12:943859. doi: 10.3389/fcimb.2022.943859. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36204638 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical